J&J | JNJ - Trade Creditors


J&J reported $10.46B in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Abbott USD 4.24B 117M Dec/2025
Amgen USD 19.52B 1.37B Mar/2026
AstraZeneca USD 22.51B 2.78B Mar/2026
Baxter International USD 1.09B 87M Mar/2026
Bayer EUR 6.59B 496M Mar/2026
Becton, Dickinson and Co. USD 5.93B 204M Mar/2026
Biogen USD 358.5M 73.5M Mar/2026
Boston Scientific USD 1.14B 3M Mar/2026
Bristol-Myers Squibb USD 4.23B 659M Mar/2026
CONMED USD 105.42M 11.77M Mar/2026
Cooper Companies USD 233.3M 7.5M Mar/2026
Dexcom USD 1.94B 109.1M Mar/2026
Edwards Lifesciences USD 181.1M 46.4M Mar/2026
Eli Lilly USD 5.03B 350M Mar/2026
Gilead Sciences USD 645M 70M Mar/2026
GlaxoSmithKline GBP 14.34B 1.05B Mar/2026
Globus Medical USD 103.66M 4.81M Mar/2026
Insulet USD 149.8M 74.8M Mar/2026
Integra LifeSciences USD 87.95M 7.78M Mar/2026
Intuitive Surgical USD 1.85B 68.6M Mar/2026
J&J USD 10.46B 1.53B Mar/2026
Medtronic USD 2.57B 12M Dec/2025
Merck USD 3.86B 541M Mar/2026
Merit Medical Systems USD 67.85M 7.3M Mar/2026
Novartis USD 4.32B 134M Mar/2026
Pfizer USD 4.51B 734M Mar/2026
Regeneron Pharmaceuticals USD 1.03B 4.81B Mar/2026
Roche Holding CHF 5.78B 1.27B Dec/2025
Sanofi EUR 22.71B 219M Mar/2026
Stryker USD 1.8B 301M Dec/2025
Tandem Diabetes Care USD 59.86M 12.79M Mar/2026
Teva Pharmaceutical Industries USD 2.6B 65M Mar/2026
Vertex Pharmaceuticals USD 3.47B 40.6M Mar/2026
Zimmer Biomet Holdings USD 361.2M 58.2M Mar/2026
Zoetis USD 507M 20M Mar/2026